Advertisement

Search Results for "Dengue Shock Myocarditis"

03:29 EDT 25th May 2013 | BioPortfolio

Original Source: Acute myocarditis in dengue hemorrhagic fever: a case report and review of cardiac complications in dengue-affected patients.

We report a case of dengue hemorrhagic fever (DHF) complicated by acute myocarditis and review the literature. A 65-year-old woman experienced DHF due to dengue virus serotype 3, complicated with acute myocarditis and acute pulmonary edema. Clinically this masqueraded as acute myocardial infarction, with an electrocardiographically depressed ST segment in precordial leads and elevated serum cardiac-specific troponin I level. Under supportive management, the patient recovered 3 days later. A total of 18 pert...

Matching Channels

Dengue

Dengue Virus Vaccines

It is estimated that about 100 million cases of infection by Dengue virus occur each year and that nearly half the world’s population is at risk of Dengue virus infection. At present, no vacci...

Dengue Hemorrhagic Fever

Shock

Hypovolemic shock

Matching News

Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis

Although great progress has been made in the field of dengue research, there are still many unanswered questions concerning the interactions between dengue virus and the human immune system. In this O...

Dengue Test Using Flu Diagnostic Equipment Approved, USA

The US Food and Drug Administration has approved a new diagnostic test, the CDC DENV-1-4 Real Time RT PCR Assay developed by the Centers for Disease Control and Prevention to detect the dengue virus i...

Dengue Vaccine Initiative welcomes latest progress in vaccine development

(Sabin Vaccine Institute) Today, the Dengue Vaccine Initiative welcomed new clinical trial results that reveal progress in developing the first-ever dengue vaccine. In a publication in the Lancet, pha...

Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur

The Dengue Vaccine Initiative (DVI) has welcomed new clinical trial results that reveal progress in developing the first-ever dengue vaccine. In a publication in The Lancet, pharmaceutical company San...

Cross-Reactive Dengue Fully Human Monoclonal Antibodies

Among the arthropod-borne flaviviruses, the four dengue virus serotypes, dengue type 1 virus (DENV-1), dengue type 2 virus (DENV-2), dengue type 3 virus (DENV-3), and dengue type 4 virus (DENV-4) are...

Results of dengue vaccine trial in over 4000 Thai children: Experts respond

Researchers from France and Thailand have trialled a dengue vaccine in over 4000 Thai children. While overall there was no difference between the number of dengue cases recorded following vaccination,...

Dengue Fever Cases Have Been Seriously Underestimated -- NPR

Jason Beaubien reports on neglected tropical diseases and the increasing global disease burden of dengue that, until now, was hidden. "[A] new...study says there could be as many as 400 million dengue...

Surprising finding could alter the face of dengue vaccine development

As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study offers surprising evidence that suggests the need for a revamped approach to dengue...

Matching PubMed Articles

Neonatal Myocardial Infarction or Myocarditis?

We report a 29 week-gestation preterm infant who presented during his second week of life with cardiogenic shock. Clinical presentation and first diagnostics suggested myocardial infarction, but echo...

Acute myocarditis in dengue hemorrhagic fever: a case report and review of cardiac complications in dengue-affected patients.

We report a case of dengue hemorrhagic fever (DHF) complicated by acute myocarditis and review the literature. A 65-year-old woman experienced DHF due to dengue virus serotype 3, complicated with acut...

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.

Today, dengue viruses are the most prevalent arthropod-borne viruses in the world. Since the 1960s, numerous reports have identified a second heterologous dengue virus (DENV) infection as a principal...

Genome-Wide Expression Profiling Deciphers Host Responses Altered during Dengue Shock Syndrome and Reveals the Role of Innate Immunity in Severe Dengue.

BACKGROUND: Deciphering host responses contributing to dengue shock syndrome (DSS), the life-threatening form of acute viral dengue infections, is required to improve both the differential prognosis a...

Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.

Dengue viruses (DENV) cause 50-100 million cases of acute febrile disease every year, including 500,000 reported cases of dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Viral factors...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement